Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Strides has received US health regulator’s approval for constipation drug

Strides Shasun has got the US health regulator’s approval for Polythylene Elycol 3350 that is used in treating constipation.

Strides Shasun has said in a BSE filing that “It has received approval from the US Food and Drug Administration (USFDA) for Polyethylene Glycol 3350, powder for solution 17 grams/capful and 17 grams/packet (OTC).”

The company has said that it will be manufacturing the product at its Banglore plant and launch the product in the fourth quarter of this fiscal.

Read EquityPandit’s Technical Analysis on Nifty Pharma 

Get Daily Prediction & Stocks Tips On Your Mobile